Invivyd, Inc.

IVVD

NASDAQ

Healthcare

Biotechnology

Waltham, MA, US99 employeesadagiotx.com

$1.27

-0.06(-4.51%)

Mkt Cap $169M

$0.47

$2.88

52-Week Range

At A Glance

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United...

Revenue is primarily driven by Product (100%).

Most recently: . The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities E (2026-03-05).

$169M

Market Cap

$41M

Revenue

-$40M

Net Income

Employees99

Fundamentals

How The Business Makes Money

Revenue by Segment

Product100%($79M)

Activity

What Changed Recently

Financial Results

Mar 4, 2026

. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities E

Financial Results

Jan 7, 2026

. Item 8.01 Other Events. On January 8, 2026, the Company issued the Press Release, a copy of which is filed herewith as Exhibit 99.1 and is incorporated by ref

Peer Companies

Company	Price	Change	Market Cap	P/E
SLSSELLAS Life Sciences Grou...	$4.12	-2.26%	$586M	-31.2
GNFTGenfit S.A.	$8.95	+4.07%	$446M	-11.6
OBIOOrchestra BioMed Holdings...	$4.26	-1.81%	$249M	-3.5
CCCCC4 Therapeutics, Inc.	$2.81	+4.26%	$233M	-2.0
TARAProtara Therapeutics, Inc...	$5.11	+1.29%	$197M	-4.1
OABIOmniAb, Inc.	$1.53	-1.60%	$175M	-3.5
CDXSCodexis, Inc.	$1.79	+3.16%	$163M	-3.3
NTHINeonc Technologies Holdin...	$5.96	-2.22%	$119M	-2.9

Analyst View

Company Profile

CIK0001832038

ISINUS00534A1025

CUSIP00534A102

Phone781 819 0080

Address1601 Trapelo Road, Waltham, MA, 02451, US

SEC EDGAR